SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001804591-24-000025
Filing Date
2024-02-07
Accepted
2024-02-07 16:07:48
Documents
98
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 10-Q me-20231231.htm   iXBRL 10-Q 1922360
2 EX-31.1 me-20231231xex311.htm EX-31.1 10800
3 EX-31.2 me-20231231xex312.htm EX-31.2 10857
4 EX-32.1 me-20231231xex321.htm EX-32.1 5145
5 EX-32.2 me-20231231xex322.htm EX-32.2 5432
  Complete submission text file 0001804591-24-000025.txt   9998088

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT me-20231231.xsd EX-101.SCH 67190
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT me-20231231_cal.xml EX-101.CAL 77608
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT me-20231231_def.xml EX-101.DEF 362922
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT me-20231231_lab.xml EX-101.LAB 840931
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT me-20231231_pre.xml EX-101.PRE 585451
100 EXTRACTED XBRL INSTANCE DOCUMENT me-20231231_htm.xml XML 1663413
Mailing Address 349 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address 349 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080 (650) 938-6300
23andMe Holding Co. (Filer) CIK: 0001804591 (see all company filings)

IRS No.: 871240344 | Fiscal Year End: 0331
Type: 10-Q | Act: 34 | File No.: 001-39587 | Film No.: 24604342
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)